EUVIMEDEUVIMED entdecken
Crossref

Clinical Relevance of Lepidoglyphus destructor Sensitisation in Allergic Rhinitis: Nasal Provocation Test as in vivo Assessment

Filipa Matos Semedo, Catarina Martins, Elza Tomaz, Bárbara Cardoso, Sofia Farinha, Marta Martins, Ana Paula Pires, Filipe Inácio, Luís Taborda-Barata

International Archives of Allergy and Immunology · 2024

DOI: 10.1159/000533814 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Archives of Allergy and Immunology, 2024. Verfasst von Filipa Matos Semedo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunoallergy, Hospital da Luz Lisboa, Lisbon, Portugal, pipa.semedo@gmail.com. Hauptthemen laut MEDLINE: Immunoglobulin E, Nasal Provocation Tests, Rhinitis, Allergic, Skin Tests. Die Arbeit wurde bisher 6-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Dust mites are the leading cause of respiratory allergic diseases worldwide. Allergy to storage mites (SMs) has mostly been related to occupational exposures. However, recent studies have shown that sensitisation to SM, such as Lepidoglyphus destructor (Lep d), is of considerable importance also in urban populations, with high prevalence in dust samples of domestic environments. Co-sensitisation between house dust mites (HDMs) and SM is now regarded as very frequent in some regions, and cross-reactivity between them seems to be narrow. Therefore, SM allergenic capacity is increasingly a subject of study. The nasal provocation test (NPT), as an in vivo technique, could be considered the gold standard for the clinical relevance assessment of an allergen, in polysensitised rhinitis patients.

Objective

The objective of this study was to analyse the clinical relevance of the SM Lep d, by assessing the relationship between in vivo sensitisation and expression of allergic respiratory disease in an urban setting. Patients and Methods: In our study, we enrolled a total of 32 allergic patients with rhinitis (with or without asthma) with proven sensitisation by skin prick test (SPT) and specific IgE (sIgE) to HDMs and/or SM. Patients underwent NPT with Lep d using subjective (Lebel Symptom Score Scale) and objective measurements (peak nasal inspiratory flow [PNIF]) for assessment of nasal response.

Results

Most of the patients with positive SPT and sIgE to Lep d had a positive NPT (24/27; 89%). True Lep d allergy, assessed by a positive NPT, could be predicted by a SPT wheal size >9.7 mm and a sIgE >0.42 kUA/L, with 100%/95.7% sensitivity and 75.0%/83.3% specificity, respectively. Co-sensitisation between Lep d and Der p was high, 75.0%. Asthma was more frequent in the positive Lep d NPT group (54 vs. 12%, p < 0.05). Significantly more patients from this group reported physical exercise, nonspecific irritants, and respiratory infections as relevant triggers of respiratory symptoms (p < 0.01–p < 0.05).

Conclusions

To our knowledge, this is the first study to show that sensitisation to Lep d may have clinical relevance in a non-occupational setting. In this group, there seems to be a relationship between allergy to Lep d and severity of respiratory disease, with more bronchial inflammation, when comparing with mite-allergic patients sensitised only to HDM. Therefore, the authors consider that sensitisation to Lep d should be considered when assessing and treating allergic respiratory disease in urban environments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunoglobulin ENasal Provocation TestsRhinitis, AllergicSkin TestsAdolescentAdultAnimalsFemaleHumansMaleMiddle AgedYoung AdultAllergensClinical RelevanceMites

Stichwörter der Autor:innen

Allergic asthmaAllergic rhinitisLepidoglyphus destructorMite allergyNasal provocation testsStorage mites

Substanzen

AllergensImmunoglobulin E

Autor:innen und Institutionen

  • Department of Immunoallergy, Hospital da Luz Lisboa, Lisbon, Portugal, pipa.semedo@gmail.com.
  • Faculty of Health Sciences, University of Beira Interior, Covilhã, Portugal, pipa.semedo@gmail.com.
  • NOVA Medical School, Nova University of Lisbon, Lisbon, Portugal, pipa.semedo@gmail.com.
  • NOVA Medical School, Nova University of Lisbon, Lisbon, Portugal.
  • Comprehensive Health Research Centre (CHRC), NOVA Medical School, Nova University of Lisbon, Lisbon, Portugal.
  • Department of Immunoallergology, Hospital de São Bernardo, Centro Hospitalar de Setúbal, Setúbal, Portugal.

Zitieren

APA

Matos Semedo, F., Martins, C., Tomaz, E., Cardoso, B., Farinha, S., Martins, M., Paula Pires, A., Inácio, F., & Taborda-Barata, L. (2024). Clinical Relevance of Lepidoglyphus destructor Sensitisation in Allergic Rhinitis: Nasal Provocation Test as in vivo Assessment. International Archives of Allergy and Immunology. https://doi.org/10.1159/000533814

Vancouver

Matos Semedo F, Martins C, Tomaz E, Cardoso B, Farinha S, Martins M, et al. Clinical Relevance of Lepidoglyphus destructor Sensitisation in Allergic Rhinitis: Nasal Provocation Test as in vivo Assessment. International Archives of Allergy and Immunology. 2024. doi:10.1159/000533814

BibTeX
@article{MatosSemedo2024,
  author = {Matos Semedo, Filipa and Martins, Catarina and Tomaz, Elza and Cardoso, Bárbara and Farinha, Sofia and Martins, Marta and Paula Pires, Ana and Inácio, Filipe and Taborda-Barata, Luís},
  title = {Clinical Relevance of Lepidoglyphus destructor Sensitisation in Allergic Rhinitis: Nasal Provocation Test as in vivo Assessment},
  journal = {International Archives of Allergy and Immunology},
  year = {2024},
  doi = {10.1159/000533814}
}
Kostenlos starten →